HomeCompareISR vs ORCC

ISR vs ORCC: Dividend Comparison 2026

ISR yields 520.83% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ISR wins by $318.2K in total portfolio value
10 years
ISR
ISR
● Live price
520.83%
Share price
$0.38
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$339.6K
Annual income
$875.92
Full ISR calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — ISR vs ORCC

📍 ISR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodISRORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ISR + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ISR pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ISR
Annual income on $10K today (after 15% tax)
$44,270.83/yr
After 10yr DRIP, annual income (after tax)
$744.53/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, ISR beats the other by $743.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ISR + ORCC for your $10,000?

ISR: 50%ORCC: 50%
100% ORCC50/50100% ISR
Portfolio after 10yr
$180.5K
Annual income
$438.48/yr
Blended yield
0.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ISR
Analyst Ratings
5
Buy
1
Hold
Consensus: Buy
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ISR buys
0
ORCC buys
0
No recent congressional trades found for ISR or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricISRORCC
Forward yield520.83%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%-50%
Portfolio after 10y$339.6K$21.4K
Annual income after 10y$875.92$1.04
Total dividends collected$203.5K$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: ISR vs ORCC ($10,000, DRIP)

YearISR PortfolioISR Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$36,742$26,041.67$11,190$489.61+$25.6KISR
2$84,025$44,710.95$12,229$256.01+$71.8KISR
3$137,686$47,780.13$13,216$130.74+$124.5KISR
4$183,911$36,586.29$14,207$66.02+$169.7KISR
5$219,621$22,836.04$15,234$33.17+$204.4KISR
6$247,737$12,743.03$16,317$16.62+$231.4KISR
7$271,796$6,717.02$17,468$8.32+$254.3KISR
8$294,265$3,443.62$18,695$4.16+$275.6KISR
9$316,606$1,742.20$20,006$2.08+$296.6KISR
10$339,644$875.92$21,407$1.04+$318.2KISR

ISR vs ORCC: Complete Analysis 2026

ISRStock

Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.

Full ISR Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this ISR vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ISR vs SCHDISR vs JEPIISR vs OISR vs KOISR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.